COAs and DHTs – measure what matters
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
In this CNS whitepaper we examine how innovative methodologies and technologies are being implemented to improve the success rate of neurodegenerative clinical trials.
Maximising efficiency and flexibility with custom outsourcing
An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
17 January 2025
Watch the recording
ICON Cares is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
